Abstract:During development, pro- and anti-angiogenic factors orchestrate a complex, dynamic process to allow initial sprouting and invasion, subsequent pruning and remodeling, and finally maturation and survival of blood vessels. However, in pathological conditions such as cancer, diabetic retinopathy, macular degeneration or inflammation the same angiogenic signaling pathways are misregulated and exploited, typically resulting in poorly organized vessels with leaky and tortuous properties. In the last decade, a new class of small non-coding RNA molecules termed microRNAs (miRs) have emerged as key regulators of several cellular processes including angiogenesis. We recently profiled microRNAs that were regulated upon growth factor activation of human endothelial cells and identified miR-132 as a regulator of pathological neovascularization. We found that miR-132 was highly expressed in activated blood vessels, but was undetectable in normal endothelium. Ectopic expression of miR-132 in endothelial cells increased their proliferation and tube-forming capacity, whereas intraocular injection of an antagomir targeting miR-132, reduced postnatal retinal vascular development in mice. We identified p120RasGAP as a miR-132 target and showed that miR-132 and p120RasGAP are expressed reciprocally during pathological angiogenesis. Our observations in several in vitro and in vivo models suggest that miR-132 acts as an angiogenic switch by suppressing endothelial p120RasGAP expression, leading to Ras activation and the induction of neovascularization, whereas the application of anti–miR-132 inhibits neovascularization by maintaining vessels in the resting state. In contrast to miR-132, a highly upregulated miR during angiogenesis, we have identified miR-34 as one of the most downregulated microRNAs in response to growth factors. Conversely, miR-34a is highly upregulated during endothelial stress responses. Our observations suggest that miR-34a functions as an ‘apoptomiR’ mediating endothelial cell death during stress by regulating the Notch pathway. Taken together, our data suggests a broad regulatory network of pro and anti-angiogenic microRNAs that target defined pathways to co-ordinate vascular responses in development and disease.

MicroRNA-10a/10b represses a novel target gene mib1 to regulate angiogenesis.

Endothelial Mir-196B-5p Regulates Angiogenesis Via the Hypoxia/mir-196B-5p/hmga2/hif1α Loop.

MiR-181b suppresses angiogenesis by directly targeting cellular communication network factor 1

Two Functional Microrna-126s Repress A Novel Target Gene P21-Activated Kinase 1 to Regulate Vascular Integrity in Zebrafish

MiR-144 regulates hematopoiesis and vascular development by targeting meis1 during zebrafish development.

MicroRNA‐185 inhibits angiogenesis in human microvascular endothelial cells through targeting stromal interaction molecule 1

Microrna-200c And-150 Play An Important Role In Endothelial Cell Differentiation And Vasculogenesis By Targeting Transcription Repressor Zeb1

Zfp36l1b protects angiogenesis through Notch1b/Dll4 and Vegfa regulation in zebrafish.

Elevated Expression of Mir302-367 in Endothelial Cells Inhibits Developmental Angiogenesis Via CDC42/CCND1 Mediated Signaling Pathways

Abstract 103: MiR-4261 Controls Endothelial Cells Angiogenesis

Zebrafish Mir-462-731 Regulates Hematopoietic Specification and Pu.1-Dependent Primitive Myelopoiesis.

Microrna-1 Regulates NCC Migration and Differentiation by Targeting Sec63

Effect of overexpression of miR-15b on vascular development in zebrafish

MiR-191-5p Disturbed the Angiogenesis in a Mice Model of Cerebral Infarction by Targeting Inhibition of BDNF

MiR-106b exhibits an anti-angiogenic function by inhibiting STAT3 expression in endothelial cells

Reciprocal Antagonism Between MicroRNA-138 and SIRT1 and Its Implications for the Angiogenesis of Endothelial Cells

Role of Mir-199B-5p in Regulating Angiogenesis in Mouse Myocardial Microvascular Endothelial Cells Through HSF1/VEGF Pathway.

MicroRNA Regulation of the Pathological Angiogenic Response

MicroRNA-140-5p impairs zebrafish embryonic bone development via targeting BMP-2.

MiRNA-Directed Regulation of VEGF and Other Angiogenic Factors under Hypoxia

Microrna-22 Regulates Inflammation and Angiogenesis Via Targeting Ve-Cadherin